Alphatec (ATEC) Q2 Revenue Jumps 27%

Alphatec (NASDAQ:ATEC), a medical technology company specializing in spinal surgery solutions, reported earnings on July 31, 2025. The release showed top- and bottom-line figures (GAAP revenue and non-GAAP EPS) that easily topped analyst estimates. Revenue (GAAP) totaled $186 million, beating the consensus GAAP estimate of $178.78 million. Non-GAAP earnings per share (EPS) reached $0.02, compared to an expected non-GAAP loss of ($0.04). This marked a significant improvement from the ($0.08) non-GAAP loss in Q2 2024. Overall, the quarter saw robust growth across most core metrics, highlighted by expanded margins, accelerating surgeon adoption, and progress toward sustainable profitability. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Alphatec is focused on developing and commercializing technology and procedural solutions for spine surgery. It aims to make surgeries more predictable and efficient, mainly by integrating implants, access systems, navigation, and surgical informatics.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool